The influenza virus is a member of the Orthomyxoviridae family of segmented, single-stranded, negatively charged RNA viruses. Three different influenza virus types—A, B, and C—are included in this group. The type A viruses infect both domesticated and wild birds, horses, swine, other mammals, and humans, while the type B and C viruses only affect humans.In the United States, seasonal epidemics of disease are brought on by human influenza A and B viruses almost every winter. An influenza pandemic can be brought on by the spread of a brand-new, radically different influenza virus. Infections with influenza type C are thought to only cause a mild respiratory illness and not epidemics. Each virus subtype has undergone mutation, resulting in a variety of strains with various levels of pathogenicity; some are pathogenic to one species but not to others, and some are pathogenic to several.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V54347 | M2e, human | 251359-24-7 | M2e, human consists of 23 extracellular residues of M2 (the third integral membrane protein of influenza virus A) and is significantly conserved among all human influenza virus A strains, making it an effective and versatile vaccine candidate , protects against any human influenza A strain. |
|
V76801 | M2e, human TFA | M2e, human TFA consists of 23 extracellular residues of M2 (the third integral membrane protein of influenza virus A) and is significantly conserved among all human influenza virus A strains. | |
|
V2378 | MBX2329 HCl | 1438272-42-4 | MBX2329 is a potent inhibitor of influenza virus that can specifically inhibit hemagglutinin (HA)-mediated virus entry. |
|
V35050 | Methyl brevifolincarboxylate (Brevifolincarboxylic acid methyl ester) | 154702-76-8 | Methyl brevifolincarboxylate (Brevifolincarboxylic acid methyl ester) is a potent inhibitor of influenza virus PB2 cap binding. |
|
V54333 | Navivumab (CT-P23) | 1443004-16-7 | Navivumab (CT-P23) is an influenza A virus (influenza A virus) hemagglutinin HA monoclonal antibody (mAb). |
|
V54339 | Nepasaikosaponin K | 405229-61-0 | Nepasaikosaponin K is an anti-influenza agent. |
|
V2221 | Neuraminidase-IN-1 | 2379438-80-7 | Neuraminidase-IN-1， also known as Y-1, is a neuraminidase inhibitor, with an IC50 of 0.21 μM. |
|
V54342 | Neuraminidase-IN-12 | 2218480-15-8 | NDV-IN-1 is an antiviral compound with high neuraminidase inhibitory activity. |
|
V41113 | Neuraminidase-IN-13 | 2222067-23-2 | Neuraminidase-IN-13 (Compound 10) is a neuraminidase inhibitor (antagonist) with antiviral effects and low cytotoxic effect. |
|
V80930 | Neuraminidase-IN-14 | Neuraminidase-IN-14 is a neuraminidase (Neuraminidase) inhibitor. | |
|
V80931 | Neuraminidase-IN-15 | Neuraminidase-IN-15 is a neuraminidase (Neuraminidase) inhibitor. | |
|
V78728 | Neuraminidase-IN-16 | Neuraminidase-IN-16 (Compound 43b) is a potent neuraminidase inhibitor. | |
|
V54348 | Neuraminidase-IN-2 | 2599015-44-6 | Neuraminidase-IN-2 is an anti-influenza compound with IC50s of 0.28, 0.27, 11.50, 0.089 and 23.44 µM against H1N1, 09H1N1, H3N2, H5N1 and H5N2 respectively. |
|
V3716 | Nitazoxanide D4 | 1246819-17-9 | Nitazoxanide D4 (NTZ D4; NSC-697855 D4) is the deuterium labeled (deurated) form of Nitazoxanide, which is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent with IC50 for canine influenza virus ranges from 0.17 to 0.21 μM. |
|
V54332 | NS2 (114-121), Influenza | 184763-32-4 | NS2 (114-121), Influenza, is the 114-121 fragment of influenza nonstructural protein 2 (NS2) and is an influenza-derived antigenic determinant. |
|
V3383 | Nucleozin | 341001-38-5 | Nucleozin is a novel potent antivirus agent that targets influenza A nucleoprotein (NP), which is a multifunctional, RNA-binding protein necessary for virus replication. |
|
V34690 | Octaethylene glycol monododecyl ether (C12E8) | 3055-98-9 | Octaethylene glycol monododecyl ether (C12E8) is a nonionic detergent that can be used for membrane protein extraction. |
|
V41071 | Odesivimab (REGN-3471) | 2135632-30-1 | Odesivimab is a humanized monoclonal antibody (mAb) targeting the Ebola virus glycoprotein. |
|
V54330 | Onradivir | 2200336-20-3 | Onradivir is an effective anti-influenza virus agent. |
|
V76063 | Onradivir monohydrate | 2375241-19-1 | Onradivir monohydrate is an effective anti-influenza virus agent. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
